Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Cellular Dynamics International Inc

+ Add to Watchlist

ICEL:US

5.0700 USD 0.5700 10.11%

As of 20:10:00 ET on 01/30/2015.

Snapshot for Cellular Dynamics International Inc (ICEL)

Open: 5.4200 Day's Range: 5.0400 - 5.7800 Volume: 52,864
Previous Close: 5.6400 52wk Range: 4.7200 - 17.9000 1-Yr Rtn: -68.13%

Stock Chart for ICEL

No chart data available.
  • ICEL:US 5.0700
  • 1D
  • 1M
  • 1Y
5.6400
Interactive ICEL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ICEL

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.0100
Est. EPS (USD) (12/2014) -2.0130
Est. PEG Ratio -
Market Cap (M USD) 80.18
Shares Outstanding (M) 15.81
30 Day Average Volume 58,097
Price/Book (mrq) 1.8766
Price/Sale (ttm) 5.5873
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ICEL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ICEL

Cellular Dynamics International Inc develops and manufactures fully functioning human cells in industrial quantities to precise specifications. The Company's cells are used for drug discovery and screening, to test the safety and efficacy of their small molecule and biologic drug candidates, for stem cell banking, and in researching cellular therapeutics.

Robert J Palay "Bob"Chairman/CEO/Co-FounderThomas M PalayVice Chairman/President/Co-Founder
James A ThomsonChief Scientific Officer/Co-FounderTimothy D DaleyVP/CFO/Treasurer
More Company Profile & Key Executives for ICEL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil